SRM Assay to Indicate Cancer Therapy
US-2015376678-A1 · Dec 31, 2015 · US
Assays for detection of glycosaminoglycans
US9012168B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9012168-B2 |
| Application number | US-201113813113-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 29, 2011 |
| Priority date | Jul 29, 2010 |
| Publication date | Apr 21, 2015 |
| Grant date | Apr 21, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Disclosed herein are novel methods, assays and kits useful for the diagnosis and monitoring of subjects with mucopolysaccharidoses (MPS), The methods, assays and kits are particularly useful for detecting the presence of one or more glycosaminoglycans which correlate to MPS and its severity in a variety of biological samples.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for determining the concentration of one or both of dermatan sulfate (DS) and heparin sulfate (HS) in a sample, the method comprising (a) treating a sample with at least one of chondroitinase B and one or more heparineses, (b) combining a serine protease shown in FIG. 7 or 8 a labeled substrate for said serine protease, an inhibitor of said serine protease, and the sample under conditions and for a time suitable for cleavage of the labeled substr…
Assignees
Inventors
Classifications
Physics · mapped topic
Physics · mapped topic
Physics · mapped topic
- C12Q1/37Primary
Chemistry & Metallurgy · mapped topic
Physics · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9012168B2 cover?
- Disclosed herein are novel methods, assays and kits useful for the diagnosis and monitoring of subjects with mucopolysaccharidoses (MPS), The methods, assays and kits are particularly useful for detecting the presence of one or more glycosaminoglycans which correlate to MPS and its severity in a variety of biological samples.
- Who is the assignee on this patent?
- Ruiz Juan, Sellos-Moura Marcia, Shi Philip, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification C12Q1/37. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).